Source Feed: The Globe and Mail
Author: Alanna Smith
Publication Date: November 11, 2025 - 19:22
Stay informed
With respiratory virus season underway, here’s what to know about RSV vaccines and protection
November 11, 2025
Respiratory viruses are once again beginning their seasonal circulation, with cases of COVID-19 having already spiked while influenza and respiratory syncytial virus, or RSV, infections slowly creep up.
RSV is a leading cause of infant hospitalization in Canada, more so than its viral counterparts. This season, however, most newborns and infants will have access to nirsevimab, sold under the brand name Beyfortus.
Unpublished Newswire
The two sides have been reviewing contractual language that will form new collective agreements, but neither the company nor the union will say how long that may take.
December 3, 2025 - 09:49 | Sean Boynton | Global News - Canada
Negotiations that could have led to coverage for weight-loss drug Wegovy under Canadian public health plans are not moving forward.
December 3, 2025 - 09:49 | Ari Rabinovitch | Global News - Canada
OTTAWA — A key intelligence watchdog is calling on the government to urgently review its governing law after cancelling a review of Canada’s spy agency due to a lack of proper legal protection for its staff.
The decision to cancel the review was not taken lightly, says the head of the National Security and Intelligence Review Agency (NSIRA), because the watchdog had already found “issues of concern” with the Canadian Security Intelligence Service (CSIS).
“NSIRA’s inability to proceed with this pertinent review highlights the urgency and necessity of legislative reforms intended to...
December 3, 2025 - 09:44 | Christopher Nardi | National Post
Comments
Be the first to comment